 Dermatitis, Atopic
"Dermatitis, Atopic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. It is manifested by lichenification, excoriation, and crusting, mainly on the flexural surfaces of the elbow and knee. In infants it is known as infantile eczema.
| Descriptor ID |
D003876
|
| MeSH Number(s) |
C16.320.850.210 C17.800.174.193 C17.800.815.193 C17.800.827.210 C20.543.480.343
|
| Concept/Terms |
Dermatitis, Atopic- Dermatitis, Atopic
- Atopic Dermatitides
- Atopic Dermatitis
- Dermatitides, Atopic
- Neurodermatitis, Atopic
- Atopic Neurodermatitides
- Atopic Neurodermatitis
- Neurodermatitides, Atopic
- Neurodermatitis, Disseminated
- Disseminated Neurodermatitides
- Disseminated Neurodermatitis
- Neurodermatitides, Disseminated
- Eczema, Atopic
- Atopic Eczema
|
Below are MeSH descriptors whose meaning is more general than "Dermatitis, Atopic".
- Diseases [C]
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]
- Genetic Diseases, Inborn [C16.320]
- Skin Diseases, Genetic [C16.320.850]
- Dermatitis, Atopic [C16.320.850.210]
- Skin and Connective Tissue Diseases [C17]
- Skin Diseases [C17.800]
- Dermatitis [C17.800.174]
- Dermatitis, Atopic [C17.800.174.193]
- Skin Diseases, Eczematous [C17.800.815]
- Dermatitis, Atopic [C17.800.815.193]
- Skin Diseases, Genetic [C17.800.827]
- Dermatitis, Atopic [C17.800.827.210]
- Immune System Diseases [C20]
- Hypersensitivity [C20.543]
- Hypersensitivity, Immediate [C20.543.480]
- Dermatitis, Atopic [C20.543.480.343]
Below are MeSH descriptors whose meaning is more specific than "Dermatitis, Atopic".
This graph shows the total number of publications written about "Dermatitis, Atopic" by people in this website by year, and whether "Dermatitis, Atopic" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 | | 1998 | 1 | 0 | 1 | | 1999 | 3 | 0 | 3 | | 2000 | 3 | 1 | 4 | | 2001 | 0 | 1 | 1 | | 2002 | 5 | 1 | 6 | | 2003 | 11 | 1 | 12 | | 2004 | 6 | 1 | 7 | | 2005 | 7 | 1 | 8 | | 2006 | 11 | 1 | 12 | | 2007 | 3 | 1 | 4 | | 2008 | 13 | 0 | 13 | | 2009 | 5 | 1 | 6 | | 2010 | 15 | 4 | 19 | | 2011 | 8 | 0 | 8 | | 2012 | 6 | 2 | 8 | | 2013 | 6 | 2 | 8 | | 2014 | 7 | 1 | 8 | | 2015 | 7 | 0 | 7 | | 2016 | 9 | 1 | 10 | | 2017 | 9 | 1 | 10 | | 2018 | 19 | 1 | 20 | | 2019 | 16 | 2 | 18 | | 2020 | 4 | 0 | 4 |
To return to the timeline, click here.
Below are the most recent publications written about "Dermatitis, Atopic" by people in Profiles.
-
Wang V, Boguniewicz J, Boguniewicz M, Ong PY. The infectious complications of atopic dermatitis. Ann Allergy Asthma Immunol. 2021 01; 126(1):3-12.
-
Paller AS, Bansal A, Simpson EL, Boguniewicz M, Blauvelt A, Siegfried EC, Guttman-Yassky E, Hultsch T, Chen Z, Mina-Osorio P, Lu Y, Rossi AB, He X, Kamal M, Graham NMH, Pirozzi G, Ruddy M, Eckert L, Gadkari A. Clinically Meaningful Responses to Dupilumab in Adolescents with Uncontrolled Moderate-to-Severe Atopic Dermatitis: Post-hoc Analyses from a Randomized Clinical Trial. Am J Clin Dermatol. 2020 Feb; 21(1):119-131.
-
Meltzer LJ, Flewelling KD, Jump S, Gyorkos E, White M, Hauk PJ. Impact of atopic dermatitis treatment on child and parent sleep, daytime functioning, and quality of life. Ann Allergy Asthma Immunol. 2020 04; 124(4):385-392.
-
Simpson EL, Paller AS, Siegfried EC, Boguniewicz M, Sher L, Gooderham MJ, Beck LA, Guttman-Yassky E, Pariser D, Blauvelt A, Weisman J, Lockshin B, Hultsch T, Zhang Q, Kamal MA, Davis JD, Akinlade B, Staudinger H, Hamilton JD, Graham NMH, Pirozzi G, Gadkari A, Eckert L, Stahl N, Yancopoulos GD, Ruddy M, Bansal A. Efficacy and Safety of Dupilumab in Adolescents With Uncontrolled Moderate to Severe Atopic Dermatitis: A Phase 3 Randomized Clinical Trial. JAMA Dermatol. 2020 01 01; 156(1):44-56.
-
Kumar R, Seibold MA, Burchard EG. Atopic dermatitis, race, and genetics. J Allergy Clin Immunol. 2020 01; 145(1):108-110.
-
Simpson E, Eckert L, Gadkari A, Mallya UG, Yang M, Nelson L, Brown M, Reaney M, Mahajan P, Guillemin I, Boguniewicz M, Pariser D. Validation of the Atopic Dermatitis Control Tool (ADCT©) using a longitudinal survey of biologic-treated patients with atopic dermatitis. BMC Dermatol. 2019 11 06; 19(1):15.
-
Hoffman BC, Garcia S, Everett DC, Leung DYM, Cho CB. Association of atopic dermatitis with increased risk of anaphylaxis to egg and milk. Ann Allergy Asthma Immunol. 2019 12; 123(6):620-622.
-
Boorgula MP, Taub MA, Rafaels N, Daya M, Campbell M, Chavan S, Shetty A, Cheadle C, Barkataki S, Fan J, David G, Beaty TH, Ruczinski I, Hanifin J, Schneider LC, Gallo RL, Paller AS, Beck LA, Leung DY, Mathias RA, Barnes KC. Replicated methylation changes associated with eczema herpeticum and allergic response. Clin Epigenetics. 2019 08 23; 11(1):122.
-
Gad SC, Sullivan DW, Mujer CV, Spainhour CB, Crapo JD. Nonclinical Safety and Toxicokinetics of MnTE-2-PyP (BMX-010), a Topical Agent in Phase 2 Trials for Psoriasis and Atopic Dermatitis. Int J Toxicol. 2019 Jul/Aug; 38(4):291-302.
-
Chaudhary SK, Singh SK, Kumari P, Kanwal S, Soman SP, Choudhury S, Garg SK. Alterations in circulating concentrations of IL-17, IL-31 and total IgE in dogs with atopic dermatitis. Vet Dermatol. 2019 Oct; 30(5):383-e114.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|